SIT INVESTMENT ASSOCIATES INC - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 1 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIT INVESTMENT ASSOCIATES INC ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q3 2023$03,9130.0%0.00%
Q2 2023$03,9130.0%0.00%
Q1 2023$03,9130.0%0.00%
Q4 2022$03,9130.0%0.00%
Q3 2022$03,9130.0%0.00%
Q2 2022$03,9130.0%0.00%
Q1 2022$03,9130.0%0.00%
Q4 2021$03,9130.0%0.00%
Q2 2021$03,9130.0%0.00%
Q1 2021$03,9130.0%0.00%
Q4 2020$03,9130.00%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q3 2023
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$27,357,0009.71%
First Washington CORP 194,440$1,145,0000.64%
SPHERA FUNDS MANAGEMENT LTD. 200,000$1,178,0000.29%
KINGDON CAPITAL MANAGEMENT, L.L.C. 286,801$1,669,0000.06%
EMERALD ADVISERS, LLC 175,000$1,031,0000.06%
Pine River Capital Management L.P. 209,900$1,236,0000.02%
Alyeska Investment Group, L.P. 82,943$489,0000.01%
TFS CAPITAL LLC 19,147$113,0000.01%
HighTower Advisors, LLC 66,514$392,0000.01%
DRIEHAUS CAPITAL MANAGEMENT LLC 32,143$189,0000.01%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders